Skip to main content
Caplight Logo









Restore Vision Inc.

Restore Vision Inc.

Private
TokyoHealthcare & Life Scienceshttps://restore-vis.com/

Last Round

Series A

Dec 15, 2023

Total Funding Raised

$25.23M

Company Overview

Restore Vision Inc. is a Japanese biopharmaceutical company that develops gene therapies for patients with retinal disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyoptogeneticsretinal disordersretinitis pigmentosaadeno-associated virusAAVregenerative medicineblindness treatmentbiotech startupclinical-stage biotechvision restorationeye gene therapyintravitreal injectioninherited blindnessbiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Restore Vision Inc. Comparables

Compare Restore Vision Inc. with similar companies based on industry and business-model similarity.

Restore Vision Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nanoscope Therapeutics Inc.
86%
Ray Therapeutics
81%
Bionic Sight, Inc.
80%

Restore Vision Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 15, 2023
Series AJun 5, 2023
SeedFeb 4, 2022

Key People

Founding team and executive leadership

Yusaku Katada

CEO

Executive Team

Hikaru Miyazaki

Representative Director and COO

Executive Team

Restore Vision Inc. Investors

Notable investors and investment history

Restore Vision Inc. investors
InvestorRounds
Higin CapitalSeries A
Remiges VenturesSeries A, Seed
ANRI株式会社Series A, Seed
QB CapitalSeries A
Spiral CapitalSeries A
Kyoto University Innovation CapitalSeries A
Japan Science and Technology AgencySeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 28, 2026

    Grew 43% QoQ from 7 to 10 employees.

  • Dec 15, 2023

    $13M round led by Remiges Ventures.

Restore Vision Inc. Filings

Explore SEC and related filing metadata, where available.

Restore Vision Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Restore Vision Inc.'s valuation, stock price, and market status.

Is Restore Vision Inc. a public or private company?

Restore Vision Inc. is a private company.

What is the current stock price of Restore Vision Inc.?

Restore Vision Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Restore Vision Inc. worth (valuation)?

Valuation information for Restore Vision Inc. is not publicly available.

Can I buy Restore Vision Inc. stock?

Restore Vision Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Restore Vision Inc.'s last funding round?

Restore Vision Inc.'s most recent funding round was Series A on December 15, 2023.

Who are the main investors in Restore Vision Inc.?

Key investors in Restore Vision Inc. include Remiges Ventures, ANRI株式会社, UntroD Capital Japan Inc..

Will Restore Vision Inc. IPO soon?

No public IPO plans have been announced for Restore Vision Inc..

How can I track Restore Vision Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Restore Vision Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTokyo
Employee Range5
Year Founded2016
Last FundingDec 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?